Lakeside Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
Lakeside Advisors's PFE Position: Q2 2026 in Review
Lakeside Advisors increased its Pfizer (PFE) stake by 2% in Q2 2026, buying an estimated $5.31K and bringing the position to 10,293 shares worth $248K. The position accounts for 0.16% of the portfolio, ranked #62.
Lakeside Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $325K in Q4 2021. 1,596 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Lakeside Advisors held 10,293 shares of Pfizer worth $248K as of Q2 2026.
- Lakeside Advisors bought 203 Pfizer shares in Q2 2026, an estimated $5.31K.
- Pfizer made up 0.16% of Lakeside Advisors's portfolio in Q2 2026, its #62 holding.
- Lakeside Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Lakeside Advisors's Pfizer position peaked at $325K in Q4 2021.
- 1,596 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Lakeside Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.